7.22
+0.14%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Shanghai Shen Lian Biomedical
Its shares trade on Shanghai under the ticker 688098.SS. It has been listed since 28 October 2019. In the fiscal year to 31 December 2025, it reported revenue of CN¥288.3m and a net loss of CN¥19.1m. At that date it held total assets of CN¥1.54bn and shareholders' equity of CN¥1.39bn.
Shanghai Shen Lian Biomedical Corp. engages in the research, development, and manufacture of vaccines for the animal farming industry. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2019-10-28. The firm is committed to the research & development of foot and mouth disease vaccines, which are used to protect animals from foot and mouth diseases. The firm's main product are swine foot and mouth disease vaccines, and it also provides cattle foot and mouth disease vaccines, other swine vaccines, and other veterinary diagnostic reagents. The firm mainly sells its products within domestic market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 28 Oct 2019
- Employees
- 365
- Website
- slbio.com.cn ↗
Leadership
Pay as last reported
- Mr. Dongsheng NieChairman of the Board, since 2006CN¥1.4m
- Ms. Ruiling LiChief Financial OfficerZWD 610,000
- Mr. Bo YinChief Technology Officer
- Mr. Xu GaoGeneral Manager, since 2023ZWD 876,000
- Mr. Wenhao NieDeputy General Manager, Director, since 2022CN¥648,000
- Mr. Zhen ZhangExecutive Deputy General Manager, since 2023ZWD 804,000
- Ms. Haixia YuSecretary of the Board, Head of the Board's Office
- Mr. Eudes FabreDirector
- Mr. Guangzhi TongDirector, since 2024CN¥96,000
- Mr. Congzhou YangDirector, since 2022CN¥1.2m
- Mr. Zhiqiang YangDirector
- Mr. Jianjun LiIndependent DirectorCN¥96,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Shanghai Shen Lian Biomedical Corp. develops swine foot and mouth disease vaccines for animal farming.
- The company focuses on foot and mouth disease vaccine research and development.
- Shanghai Shen Lian Biomedical Corp. manufactures veterinary diagnostic reagents for animal health.
Weaknesses
- The company operates solely within the domestic market of China.
- Shanghai Shen Lian Biomedical Corp. has limited international presence in the pharmaceutical sector.
- The firm's product range is concentrated on foot and mouth disease vaccines.
Opportunities
- Expanding into cattle foot and mouth disease vaccine markets within China.
- Increasing demand for swine vaccines in the Chinese animal farming industry.
- Growing market for veterinary diagnostic reagents in domestic China.
Threats
- Competition from domestic pharmaceutical companies in China.
- Regulatory changes affecting vaccine manufacturing in China.
- Dependence on the Chinese animal farming industry for revenue.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.